×
AxoGen Goodwill and Intangible Assets 2010-2024 | AXGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AxoGen goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
View More
AxoGen Goodwill and Intangible Assets 2010-2024 | AXGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AxoGen goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$214.1B
Intuitive Surgical (ISRG)
$183.6B
Alcon (ALC)
$45.1B
IQVIA Holdings (IQV)
$40.2B
Edwards Lifesciences (EW)
$39.6B
IDEXX Laboratories (IDXX)
$34.7B
DexCom (DXCM)
$26.8B
Waters (WAT)
$23B
STERIS (STE)
$22.4B
SONOVA HOLDING (SONVY)
$21.9B
Hologic (HOLX)
$18.7B
Fresenius Medical Care AG KGaA (FMS)
$12.4B
Sysmex ADR (SSMXY)
$11.9B
Globus Medical (GMED)
$11.2B
Teleflex (TFX)
$9.4B
Penumbra (PEN)
$9B
Masimo (MASI)
$8.9B
Glaukos (GKOS)
$7.8B
PROCEPT BioRobotics (PRCT)
$5.1B
Integer Holdings (ITGR)
$4.5B
Inari Medical (NARI)
$3.1B
TransMedics (TMDX)
$2.9B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.8B
Nihon Kohden (NHNKY)
$2.5B
Tandem Diabetes Care (TNDM)
$2.2B
Elekta AB (EKTAY)
$2.2B
Integra LifeSciences Holdings (IART)
$2.1B
RxSight (RXST)
$2B
Alphatec Holdings (ATEC)
$1.3B